Literature DB >> 1668251

Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1-beta release from rat periosteal and human gingival fibroblasts in vitro.

H J Sismey-Durrant1, R M Hopps.   

Abstract

Lipopolysaccharide (LPS) was extracted from Porphyromonas gingivalis (W83) by the Westphal procedure, nuclease-digested and ultracentrifuged. Fibroblasts were obtained from human gingival tissue and rat periosteum, grown to confluence then stimulated in serum-free medium with 0.1, 1.0 and 10.0 micrograms/ml LPS. The levels of prostaglandin E2 (PGE2) and interleukin-1 beta (IL-1 beta) released were measured after 2, 4 and 6 d by specific radioimmunoassays. Unstimulated gingival fibroblasts produced low levels of PGE2 (24.5 +/- 1.5 (SD) ng/ml) and IL-1 beta (0.34 +/- 0.29 ng/ml). LPS stimulated statistically significant dose-related increases in PGE2 and IL-1 beta at the concentrations of LPS tested. At 10.0 micrograms/ml, LPS-stimulated fibroblasts produced 363.5 +/- 40.3 ng/ml PGE2 and 1.81 +/- 0.1 ng/ml IL-1 beta in 6 d. These results demonstrate that LPS from P. gingivalis is capable of stimulating PGE2 and IL-1 beta release from fibroblasts. This would appear to be an additional mechanism by which LPS can induce tissue breakdown in periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1668251     DOI: 10.1111/j.1399-302x.1991.tb00510.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  23 in total

1.  Feasibility of an HA2 domain-based periodontitis vaccine.

Authors:  A A DeCarlo; Y Huang; C A Collyer; D B Langley; J Katz
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Luteolin and fisetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in human gingival fibroblasts.

Authors:  Gloria Gutiérrez-Venegas; Anabel Contreras-Sánchez
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

3.  Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides.

Authors:  K Noguchi; M Shitashige; M Yanai; I Morita; T Nishihara; S Murota; I Ishikawa
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

4.  Porphyrin-mediated binding to hemoglobin by the HA2 domain of cysteine proteinases (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis.

Authors:  A A DeCarlo; M Paramaesvaran; P L Yun; C Collyer; N Hunter
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

5.  Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin.

Authors:  Y Zubery; C R Dunstan; B M Story; L Kesavalu; J L Ebersole; S C Holt; B F Boyce
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

6.  Characterization of inhibitory effects of suspected periodontopathogens on osteogenesis in vitro.

Authors:  P M Loomer; R P Ellen; H C Tenenbaum
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures.

Authors:  M Tamura; M Tokuda; S Nagaoka; H Takada
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis.

Authors:  H Kumada; Y Haishima; T Umemoto; K Tanamoto
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

9.  Internal prostaglandin synthesis augments osteoprotegerin production in human gingival fibroblasts stimulated by lipopolysaccharide.

Authors:  M Kiji; T Nagasawa; D Hormdee; R Yashiro; H Kobayashi; K Noguchi; H Nitta; Y Izumi; I Ishikawa
Journal:  Clin Exp Immunol       Date:  2007-06-05       Impact factor: 4.330

10.  LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.

Authors:  T Nagasawa; H Kobayashi; M Kiji; M Aramaki; R Mahanonda; T Kojima; Y Murakami; M Saito; Y Morotome; I Ishikawa
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.